IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Outcomes of Surgically Managed Spontaneous Tumors in 114 Client-owned Dogs

  • Ji-Won Choi (Department of Veterinary Surgery, College of Veterinary Medicine, Konkuk University) ;
  • Hun-Young Yoon (Department of Veterinary Surgery, College of Veterinary Medicine, Konkuk University) ;
  • Soon-Wuk Jeong (Department of Veterinary Surgery, College of Veterinary Medicine, Konkuk University)
  • Received : 2016.01.06
  • Accepted : 2016.03.19
  • Published : 2016.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Medical records of 139 tumors from 114 dogs that underwent surgery from May 2010 through March 2015 were retrospectively reviewed. Among 114 dogs, females (64.9%) were significantly more common than males (35.1%) (p<0.05). Dogs aged 6 to 10 years were more presented than non-tumor patients, however, there was no significant difference. The mean age (±SD) was 10.3±3.0 years. Although we found no significant difference of breed predisposition, the most common breed was Maltese (19.3%), followed by Shih-Tzu (14.0%), and Yorkshire terrier (13.2%). Proportional morbidity ratios (PMRs) of mammary gland, oral cavity, and skin tumors were high in Poodles, Yorkshire terriers, and Golden retrievers, respectively. Mammary gland (36.0%) was the most common site, followed by skin and soft tissues (12.2%), oral cavity (10.8%), and digestive organs (8.6%), but there was no significant difference. The objectives of surgery were curative surgery (86.2%), biopsy (4.9%), and palliative surgery (6.5%). In this study, 123 of 139 tumors had histopathological diagnoses. Adenocarcinoma was the most common type (n=24), followed by adenoma (n=17), soft tissue sarcoma (n=13), benign mixed tumor (n=5), and others (n=64). Recurrence or suspected metastasis was identified in 26 dogs. Median survival times of malignant mammary gland tumors, skin and subcutaneous tumors, and splenic tumors were 1,563.0±1,201.7, 469, and 128 days, respectively.

Keywords

References

  1. Jemal, A., F. Bray, M. Melissa, J. Ferlay, E Ward, and D. Forman. 2011. Global cancer statistics. CA Cancer J. Clin. 61: 69-90.  https://doi.org/10.3322/caac.20107
  2. Siegel, R., J. Ma, Z. Zou, and A. Jemal. 2014. Cancer statistics, 2014. CA Cancer J. Clin. 64: 9-29.  https://doi.org/10.3322/caac.21208
  3. Fleming, J. M., K. E. Creevy, and D. E. Promislow. 2011. Mortality in North American dogs from 1984 to 2004: An investigation into age-, size-, and breed-related causes of death. J. Vet. Intern. Med. 25: 187-198.  https://doi.org/10.1111/j.1939-1676.2011.0695.x
  4. Inoue, M., A. Hasegawa, Y. Hosoi, and K. Sugiura. 2015. A current life table and causes of death for insured dogs in Japan. Prev. Vet. Med. 120: 210-218.  https://doi.org/10.1016/j.prevetmed.2015.03.018
  5. Misdorp, W. 1996. Veterinary cancer epidemiology. Vet. Q. 18: 32-36.  https://doi.org/10.1080/01652176.1996.9694610
  6. Bronden, L. B., A. Flagstad, and A. T. Kristensen. 2007. Veterinary cancer registries in companion animal cancer: a review. Vet. Comp. Oncol. 5: 133-144.  https://doi.org/10.1111/j.1476-5829.2007.00126.x
  7. MacVean, D. W., A. W. Monlux, P. S. Jr. Anderson, S. L. Silberg, and J. F. Roszel. 1978. Frequency of canine and feline tumors in a defined population. Vet. Pathol. 15: 700-715.  https://doi.org/10.1177/030098587801500602
  8. Dobson, J. M., S. Samuel, H. Milstein, K. Rogers, and J. L. Wood. 2002. Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J. Small Anim. Pract. 43: 240-246.  https://doi.org/10.1111/j.1748-5827.2002.tb00066.x
  9. Merlo, D. F., L. Rossi, C. Pellegrino, M. Ceppi, U. Cardellino, C. Capurro, A. Ratto, P. L. Sambucco, V. Sestito, G. Tanara, and V. Bocchini. 2008. Cancer incidence in pet dogs: Findings of the animal tumor registry of Genoa, Italy. J. Vet. Intern. Med. 22: 976-984.  https://doi.org/10.1111/j.1939-1676.2008.0133.x
  10. Vascellari, M., E. Baioni, G. Ru. A. Carminato, and F. Mutinelli. 2009. Animal tumour registry of two provinces in northern Italy: Incidence of spontaneous tumours in dogs and cats. BMC Vet. Res. 5: 39. 
  11. Bronden, L. B., S. S. Nielsen, N. Toft, and A. T. Kristensen. 2010. Data from the danish veterinary cancer registry on the occurrence and distribution of neoplasms in dogs in Denmark. Vet. Rec. 166: 586-590.  https://doi.org/10.1136/vr.b4808
  12. Pakhrin. B., M. S. Kang, I. H. Bae, M. S. Park, H. Jee, M. H. You, J. H. Kim, B. I. Yoon, Y. K. Choi, and D. Y. Kim. 2007. Retrospective study of canine cutaneous tumors in Korea. J. Vet. Sci. 8: 229-236.  https://doi.org/10.4142/jvs.2007.8.3.229
  13. Kim, Y. H., N. K. Ahn, I. S. Roh, B. I. Yoon, and J. H. Han. 2009. Retrospective investigation of canine skin and mammary tumors in Korea. J. Vet. Clin. 26: 556-562. 
  14. Dorn, C. R., D. O. Taylor, R. Schneider, H. H. Hibbard, and M. R. Klauber. 1968. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J. Natl. Cancer Inst. 40: 307-331. 
  15. Fritz, A., C. Percy, A. Jack, K. Shanmugaratnam, L. Sobin, D. Parkin, and S. Whelan. 2013. In International Classification of Diseases for Oncology (ICD-O). 3rded. A. Fritz, C. Percy, A. Jack. K. Shanmugaratnam, L. Sobin, D. Parkin, and S. Whelan, eds. World Health Organization, Geneva. p.1-242. 
  16. Cohen, D., J. S. Reif, R. S. Brodey, and H. Keiser. 1974. Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res. 34: 2859-2868. 
  17. Mitchell, L., F. A. De la Iglesia, M. S. Wenkoff, A. A. Van Dreumel, and G. Lumb. 1974. Mammary tumors in dogs: survey of clinical and pathological characteristics. Can. Vet. J. 15: 131-138. 
  18. Moe, L. 2001. Population-based incidence of mammary tumours in some dog breeds. J. Reprod. Fertil. Suppl. 57: 439-443. 
  19. Todorova, I. 2006. Prevalence and etiology of the most common malignant tumours in dogs and cats. B. J. Vet. Med. 9: 85-98. 
  20. Rivera, P., M. Melin, T. Biagi. T. Fall, J. Haggstrom, K. Lindblad-Toh, and H. von Euler. 2009. Mammary tumor development in dogs is associated with BRCA1 and BRCA2. Cancer Res. 69: 8770-8774.  https://doi.org/10.1158/0008-5472.CAN-09-1725
  21. Pires, I., A. Alves, F. Queiroga, F. Silva, and C. Lopes. 2013. Regression of canine cutaneous histiocytoma: reduced proliferation or increased apoptosis? Anticancer Res. 33: 1397-1400. 
  22. Butler, M., N. Bonnett, and L. Page. 2013. Epidemiology and the evidence-based medicine approach. In Withrow & MacEwen's Small Animal Clinical Oncology, 5th ed. S. J. Withrow, D. M. Vail, and R. L. Page, eds. Elsevier saunders, St. Louis, Missouri. p.68-82. 
  23. Ettinger, S. N. 2003. Principles of treatment for canine lymphoma. Clin. Tech. Small. Anim. Pract. 18: 92-97.  https://doi.org/10.1053/svms.2003.36622
  24. Spodnick, G. J., J. Berg, W. M. Rand, S. H. Schelling, G. Couto, H. J. Harvey, R. A. Henderson, G. MacEwen, N. Mauldin, D. L. McCaw. A. S. Moore, W. Morrison, A. M. Norris, J. O'Bradovich, D. A. O'Keefe, R. Page, D. Ruslander, J. Klausner, R. C. Straw, and J. P. Thompson. 1992. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J. Am. Vet. Med. Assoc. 200: 995-999.  https://doi.org/10.2460/javma.1992.200.07.995
  25. Kuntz, C. A., W. S. Dernell, B. E. Powers, C. Devitt, R. C. Straw, and S. J. Withrow. 1997. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). J. Am. Vet. Med. Assoc. 211: 1147-1151.  https://doi.org/10.2460/javma.1997.211.09.1147
  26. Spangler, W. L., and P. H. Kass. 1997. Pathologic factors affecting postsplenectomy survival in dogs. J. Vet. Intern. Med. 11: 166-171.  https://doi.org/10.1111/j.1939-1676.1997.tb00085.x
  27. Wood, C. A., A. S. Moore, J. M. Gliatto, L. A. Ablin, R. J. Berg, and W. M. Rand. 1998. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993). J. Am. Anim. Hosp. Assoc. 34: 417-421.  https://doi.org/10.5326/15473317-34-5-417
  28. Jermyn, K., B. Duncan, and X. Lascelles. 2011. Principles of oncological surgery. In: BSAVA Manual of Canine and Feline Oncology, 3rded. M. Dobson, and D. Lascelles, eds, BSAVA, Quedgeley, Gloucester. p.44-59. 
  29. Moore, G. E. A. Sandberg, and J. R. Schubarg. 1957. Clinical and experimental observations of the occurrence and fate of tumor cells in the blood stream. Ann. Surg. 146: 580-587.  https://doi.org/10.1097/00000658-195710000-00005
  30. Sugarbaker, P. H. 2008. Overview of peritoneal carcinomatosis. Cancerologia 3: 119-124. 
  31. Park, S. Y., G. S. Choi, J. S. Park, H. J. Kim, J. P. Ryuk, and W. H. Choi. 2012. Influence of surgical manipulation and surgical modality on the molecular detection of circulating tumor cells from colorectal cancer. J. Korean Surg. Soc. 82: 356-364.  https://doi.org/10.4174/jkss.2012.82.6.356
  32. Atkin, G., A. Chopada, and I. Mitchell. 2005. Colorectal cancer metastasis: in the surgeon's hands? Int. Semin. Surg. Oncol. 2: 5. 
  33. Romsdahl, M. M., R. G. McGrath, E. Hoppe, and E. A. McGrew. 1965. Experimental model for the study of tumor cells in the blood. Acta. Cytol. 9: 141-145. 
  34. Nishizaki, T., T. Matsumata , T. Kanematsu, C. Yasuaga, and K. Sugimachi. 1990. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis. J. Surg. Res. 49: 92-97.  https://doi.org/10.1016/0022-4804(90)90116-J
  35. Abgral, R., G. Valette, P. Robin, J. Rousset, N. Keromnes, P. Y. Le Roux, R. Marianowski, and P. Y. Salaun. 2015. Prognostic evaluation of percentage variation of metabolic tumor burden calculated by dual-phase 18FDG PET-CT imaging in patients with head and neck cancer. Head & Neck 55: 691-696. 
  36. Morris, J. S., J. M. Dobson, D. E. Bostock, and E. O'Farrell. 1998. Effect of ovariohysterectomy in bitches with mammary neoplasms. Vet. Rec. 142: 656-658.  https://doi.org/10.1136/vr.142.24.656
  37. Yamagami, T., T. Kobayashi, K. Takahashi, and M. Sugiyama. 1996. Influence of ovariohysterectomy at the time of mastectomy on the prognosis for canine malignant mammary tumors. J. Small Anim. Pract. 37: 462-464.  https://doi.org/10.1111/j.1748-5827.1996.tb01740.x
  38. Sorenmo, K. U., F. S. Shofer, and M. H. Goldschmidt. 2000. Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J. Vet. Intern. Med. 14: 266-270. https://doi.org/10.1111/j.1939-1676.2000.tb01165.x